Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 2/20 | 0.65 |
| ▸ | MME | P08473 | 2/20 | 0.65 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.65 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.65 |
| ▸ | CTSL | P07711 | 2/20 | 0.64 |
| ▸ | CTSB | P07858 | 2/20 | 0.64 |
| ▸ | CTSS | P25774 | 2/20 | 0.64 |
| ▸ | CTSK | P43235 | 2/20 | 0.64 |
| ▸ | TACR1 | P25103 | 2/20 | 0.62 |
| ▸ | TYR | P14679 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10507966 | 1.00 | ECE1 (0.65) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL6118298 | 1.00 | ECE1 (0.65) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL1702159 | 1.00 | ECE1 (0.65) | ECE1MMEITGB3ITGA2BCTSL | |
| Water SCHEMBL8165165 | 0.99 | CTSL (0.66) | ECE1MMEITGB3ITGA2BCTSL | |
| Water SCHEMBL8394834 | 0.99 | CTSL (0.66) | ECE1MMEITGB3ITGA2BCTSL | |
| Hydrochloric Acid SCHEMBL11635370 | 0.99 | ECE1 (0.64) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL20678118 | 0.95 | MME (0.67) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL29400351 | 0.95 | MME (0.67) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL10727026 | 0.95 | MME (0.67) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL30600471 | 0.95 | MME (0.67) | ECE1MMEITGB3ITGA2BCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320333-A1 | COMPOSITION FOR PREPARING POLYCAPROLACTONE SHAPE MEMORY MATERIAL, AND POLYCAPROLACTONE SHAPE MEMORY MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2025-10-16 | — | — | US | claimed |
| CN-119530984-A | N-carbobenzoxy-L-tyrosine monocrystal and preparation method thereof | 中国科学院过程工程研究所 | 2025-02-28 | — | — | CN | claimed |
| EP-4410863-A1 | COMPOSITION FOR PREPARING POLYCAPROLACTONE SHAPE MEMORY MATERIAL, AND POLYCAPROLACTONE SHAPE MEMORY MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | China Petroleum & Chemical Corporation (CN) | 2024-08-07 | — | — | EP | claimed |
| CN-117004665-A | Method for synthesizing full-color system bionic pigment with amino acid coding property by biological enzyme method | 天津大学 | 2023-11-07 | — | — | CN | claimed |
| US-20230322743-A1 | NOVEL SAFRYLAMINE DERIVATIVES HAVING PRODRUG PROPERTIES | MIHKAL GMBH (CH) | 2023-10-12 | — | — | US | claimed |
| US-11779653-B2 | Multi-armed polyrotaxane platform for protected nucleic acid delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-10 | — | — | US | claimed |
| EP-4211130-A1 | NOVEL SAFRYLAMINE DERIVATIVES HAVING PRODRUG PROPERTIES | COMPASS Pathfinder Limited (GB) | 2023-07-19 | — | — | EP | claimed |
| WO-2023072242-A1 | COMPOSITION FOR PREPARING POLYCAPROLACTONE SHAPE MEMORY MATERIAL, AND POLYCAPROLACTONE SHAPE MEMORY MATERIAL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 中国石油化工股份有限公司 | 2023-05-04 | — | — | WO | claimed |
| CN-116041680-A | Composition for preparing polycaprolactone shape memory material, and preparation method and application thereof | 中石化南京化工研究院有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-115581629-A | Method for improving hair dyeing stability based on enzymatic oxidation | 天津大学 | 2023-01-10 | — | — | CN | claimed |
| CN-113244119-A | Method for dyeing hair in color based on enzymatic oxidation of tyrosine derivative | 天津大学 | 2021-08-13 | — | — | CN | claimed |
| WO-2020252713-A1 | MODIFIED HYDROPHOBIC AUXILIARY MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF | 浙江智达药业有限公司 | 2020-12-24 | — | — | WO | claimed |
| CN-112110834-A | Modified hydrophobic auxiliary material and preparation method and application thereof | 浙江智达药业有限公司 | 2020-12-22 | — | — | CN | claimed |
| EP-0728469-B1 | An endermic liniment | SHISEIDO CO LTD (JP) | 2003-01-15 | — | — | EP | claimed |
| US-6031127-A | Process for preparing L-p-boronophenylalanine and intermediate for preparing the same | TOHOKU UNIVERSITY (JP) | 2000-02-29 | — | — | US | claimed |
| EP-0611774-B1 | Production of amides and peptides without racemization in the presence of catalytic amounts of a N-hydroxy-compound | HOFFMANN LA ROCHE (CH) | 1999-05-26 | — | — | EP | claimed |
| US-5767158-A | FOR BLEACHING SKIN | SHISEIDO CO., LTD. (JP) | 1998-06-16 | — | — | US | claimed |
| US-5750649-A | REACTING ACID AND AMINE IN PRESENCE OF CARBODIIMIDE DEHYDRATING AGENT AND N-HYDROXY COMPOUND; PEPTIDES | HOFFMANN-LA ROCHE INC. (US) | 1998-05-12 | — | — | US | claimed |
| EP-0611774-A1 | Production of amides and peptides without racemization in the presence of catalytic amounts of a N-hydroxy-compound | F. HOFFMANN-LA ROCHE AG (CH) | 1994-08-24 | — | — | EP | claimed |
| EP-0049500-B1 | TYROSINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN THE SYNTHESIS OF PEPTIDES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1984-02-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779653-B2 | Multi-armed polyrotaxane platform for protected nucleic acid delivery | POLRMT, TLR9, CTDSP1 | ECE1 3346/4885MME 625/4885ITGB3 3269/4885 |
| US-20230322743-A1 | NOVEL SAFRYLAMINE DERIVATIVES HAVING PRODRUG PROPERTIES | HTR2A, HTR2C, HTR1D | ECE1 2100/4885MME 91/4885ITGB3 3634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.